Q1 2021 Holdings
Filed 2021-05-13 | 13 holdings | $330.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Management, Inc.(CGEM) | Common | 230031106 | $329.8M | 7,913,887 | 99.9% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $81.6K | 3,898,422 | 0.0% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $80.5K | 2,355,557 | 0.0% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $74.4K | 3,370,982 | 0.0% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $63.5K | 2,069,749 | 0.0% |
| MEI Pharma, Inc. | Common | 552798202 | $34.8K | 10,137,859 | 0.0% |
| Oncorus, Inc. | Common | 68236R103 | $33.1K | 2,377,031 | 0.0% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $25.5K | 269,186 | 0.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $22.3K | 927,794 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $20.3K | 2,331,534 | 0.0% |
| Merus N.V. | Common | N5749R100 | $14.6K | 700,879 | 0.0% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $10.2K | 337,291 | 0.0% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $5.3K | 218,027 | 0.0% |